| Medical and Health Sciences | Lifetime | 46 | DK 3 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 23 | DK 1 | 99.99 |
| Surgery | Lifetime | 7 | DK 3 | 99.99 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 20 | DK 2 | 99.91 |
| Pulmonary and Respiratory Medicine | Lifetime | 158 | DK 2 | 99.81 |
| Genetics | Lifetime | 217 | DK 2 | 99.51 |
| Epidemiology | Lifetime | 355 | DK 4 | 99.57 |
| Cancer Research | Lifetime | 108 | DK 2 | 99.42 |
| Medical Physiology | Lifetime | 267 | DK 7 | 99.57 |
| Cardiology and Cardiovascular Medicine | Lifetime | 281 | DK 6 | 99.64 |
| Pathology and Forensic Medicine | Lifetime | 333 | DK 7 | 98.74 |
| Hematology | Lifetime | 701 | DK 10 | 93.92 |
| Nephrology | Lifetime | 889 | DK 11 | 84.75 |
| Surgery | 2021-2025 | 3 | DK 1 | 99.99 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 25 | DK 2 | 99.77 |
| Epidemiology | 2021-2025 | 114 | DK 2 | 99.27 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 122 | DK 1 | 99.19 |
| Cancer Research | 2021-2025 | 39 | DK 1 | 98.39 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 191 | DK 4 | 98.80 |
| Medical Physiology | 2021-2025 | 269 | DK 3 | 96.41 |
| Genetics | 2021-2025 | 336 | DK 6 | 90.87 |
| Nutrition and Dietetics | 2021-2025 | 389 | DK 7 | 82.20 |
| Cancer, Lipids, and Metabolism | Lifetime | 1 | DK 1 | 99.98 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 1 | DK 1 | 99.98 |
| Lipoproteins and Cardiovascular Health | Lifetime | 2 | DK 2 | 99.98 |
| Lipid metabolism and disorders | Lifetime | 2 | DK 1 | 99.86 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 22 | DK 3 | 99.83 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 21 | DK 2 | 99.71 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 50 | DK 2 | 99.74 |
| Liver Disease Diagnosis and Treatment | Lifetime | 225 | DK 2 | 99.64 |
| Cardiovascular Disease and Adiposity | Lifetime | 62 | DK 2 | 99.59 |
| Genetic Associations and Epidemiology | Lifetime | 49 | DK 1 | 99.58 |
| Aortic Thrombus and Embolism | Lifetime | 4 | DK 1 | 99.17 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 149 | DK 3 | 99.49 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 44 | DK 2 | 98.32 |
| Diet and metabolism studies | Lifetime | 309 | DK 12 | 99.34 |
| Nutrition, Genetics, and Disease | Lifetime | 60 | DK 5 | 98.91 |
| Folate and B Vitamins Research | Lifetime | 120 | DK 2 | 98.40 |
| Respiratory Support and Mechanisms | Lifetime | 265 | DK 2 | 99.21 |
| Asthma and respiratory diseases | Lifetime | 378 | DK 8 | 99.05 |
| Vitamin D Research Studies | Lifetime | 155 | DK 4 | 98.61 |
| Telomeres, Telomerase, and Senescence | Lifetime | 102 | DK 4 | 97.49 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 639 | DK 7 | 98.38 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 746 | DK 14 | 98.12 |
| Hormonal Regulation and Hypertension | Lifetime | 471 | DK 3 | 97.86 |
| Protease and Inhibitor Mechanisms | Lifetime | 372 | DK 12 | 97.62 |
| Diet, Metabolism, and Disease | Lifetime | 477 | DK 15 | 97.71 |
| Iron Metabolism and Disorders | Lifetime | 399 | DK 4 | 97.51 |
| Cardiovascular Health and Disease Prevention | Lifetime | 601 | DK 7 | 97.40 |
| Pediatric health and respiratory diseases | Lifetime | 427 | DK 10 | 97.24 |
| Alcohol Consumption and Health Effects | Lifetime | 428 | DK 8 | 96.98 |
| Studies on Chitinases and Chitosanases | Lifetime | 90 | DK 7 | 96.34 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 600 | DK 15 | 97.37 |
| BRCA gene mutations in cancer | Lifetime | 465 | DK 4 | 96.87 |
| Diabetes and associated disorders | Lifetime | 859 | DK 29 | 97.07 |
| Hemoglobinopathies and Related Disorders | Lifetime | 772 | DK 4 | 96.65 |
| Nutritional Studies and Diet | Lifetime | 839 | DK 20 | 97.43 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 253 | DK 13 | 95.11 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 939 | DK 18 | 95.39 |
| Renin-Angiotensin System Studies | Lifetime | 658 | DK 6 | 94.60 |
| Cholesterol and Lipid Metabolism | Lifetime | 750 | DK 7 | 94.11 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 581 | DK 2 | 90.79 |
| Vitamin C and Antioxidants Research | Lifetime | 998 | DK 22 | 89.80 |
| Apelin-related biomedical research | Lifetime | 682 | DK 6 | 87.09 |
| Coffee research and impacts | Lifetime | 888 | DK 6 | 83.60 |
| Clusterin in disease pathology | Lifetime | 843 | DK 4 | 47.04 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 1 | DK 1 | 99.93 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 3 | DK 1 | 99.89 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 3 | DK 1 | 99.93 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 3 | DK 2 | 99.75 |
| Lipid metabolism and disorders | 2021-2025 | 2 | DK 1 | 99.30 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 58 | DK 2 | 99.03 |
| Aortic Thrombus and Embolism | 2021-2025 | 1 | DK 1 | 98.78 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 26 | DK 2 | 97.88 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 317 | DK 5 | 98.42 |
| Genetic Associations and Epidemiology | 2021-2025 | 182 | DK 2 | 95.91 |
| Diet and metabolism studies | 2021-2025 | 478 | DK 12 | 95.40 |
| Peripheral Artery Disease Management | 2021-2025 | 203 | DK 1 | 94.37 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 919 | DK 3 | 91.15 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 620 | DK 7 | 90.24 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 526 | DK 5 | 87.01 |
| Folate and B Vitamins Research | 2021-2025 | 303 | DK 4 | 83.13 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 324 | DK 4 | 82.94 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 256 | DK 10 | 79.39 |
| Iron Metabolism and Disorders | 2021-2025 | 893 | DK 6 | 79.58 |
| Respiratory and Cough-Related Research | 2021-2025 | 823 | DK 14 | 77.82 |
| Nutrition, Genetics, and Disease | 2021-2025 | 878 | DK 14 | 68.89 |
| Fatty Acid Research and Health | 2021-2025 | 977 | DK 13 | 66.97 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 468 | DK 14 | 61.08 |
| Magnesium in Health and Disease | 2021-2025 | 411 | DK 7 | 54.02 |
| GDF15 and Related Biomarkers | 2021-2025 | 963 | DK 21 | 40.79 |